bisantrene has been researched along with Colonic Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Marco, C; Folini, M; Palumbo, M; Pivetta, C; Sissi, C; Zaffaroni, N; Zagotto, G | 1 |
| Ahmed, T; Harper, HD; Kemeny, NE; Michaelson, RA | 1 |
| Kovach, JS; Powis, G | 1 |
| Barlogie, B; Drewinko, B; Trujillo, JM; Yang, LY | 1 |
| Hahn, RG; Jones, AR; Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J | 1 |
| Anbar, D; Forastiere, AA; Perry, MC; Richards, F; Weiss, RB | 1 |
| Annable, T; Arceci, RJ; Collins, KI; Durr, FE; Greenberger, LM; Ho, JP; Ritke, MK; Slovak, ML; Yalowich, JC; Zhang, XP | 1 |
7 other study(ies) available for bisantrene and Colonic Neoplasms
| Article | Year |
|---|---|
Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer.
Topics: Anthracenes; Antibiotics, Antineoplastic; Cell Line, Tumor; Colonic Neoplasms; G-Quadruplexes; Humans; Inhibitory Concentration 50; Isomerism; Melanoma; Molecular Structure; Nucleic Acid Denaturation; Osteosarcoma; Structure-Activity Relationship; Taq Polymerase; Telomerase; Telomere | 2010 |
Phase II trial of bisantrene in advanced colorectal carcinoma.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms | 1983 |
Disposition of bisantrene in humans and rabbits: evidence for intravascular deposition of drug as a cause of phlebitis.
Topics: Animals; Anthracenes; Colonic Neoplasms; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Phlebitis; Rabbits; Rectal Neoplasms; Urinary Bladder Neoplasms | 1983 |
Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitro.
Topics: Anthracenes; Anthraquinones; Cell Line; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Humans; Mitoxantrone; Time Factors | 1983 |
Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinoma.
Topics: Adenocarcinoma; Aged; Anthracenes; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rectal Neoplasms | 1983 |
Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Rectal Neoplasms | 1982 |
P-glycoprotein mediates profound resistance to bisantrene.
Topics: Anthracenes; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Chromosome Banding; Chromosomes, Human; Clone Cells; Colonic Neoplasms; DNA Primers; Drug Resistance, Multiple; Humans; In Situ Hybridization, Fluorescence; KB Cells; Melanoma; Molecular Sequence Data; Polymerase Chain Reaction; Recombinant Proteins; Transfection; Tumor Cells, Cultured | 1994 |